ArticleFrontiers in pharmacology2025
A randomized controlled trial of Shengji ointment combined with bromelain in promoting healing of tendon-exposed diabetic foot wounds: integrated 16S rDNA sequencing and metabolomics analysis.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metabolism, senescence, and natural products: new perspectives on wound healing in diabetes.Frontiers in nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic foot tendon exposures are prone to infection, necrosis, and prolonged treatment cycle, not only hinder wound healing, but may also lead to amputation and even life-threatening. Utilizing Shengji ointment (a Traditional Chinese Medicine, TCM) combined with bromelain for treating diabetic foot tendon exposure wounds has demonstrated preliminary efficacy. However, the underlying mechanisms, as well as the changes in wound microbiota and metabolites before and after treatment, still warrant further investigation. Methods: This study used a randomized controlled trial design, with 60 patients randomly assigned to either the experimental group or the control group in a 1:1 ratio. The treatment cycle was 4 weeks. The experimental group was treated with Shengji ointment combined with bromelain, while the control group was treated with hydrocolloid dressing. The clinical efficacy of the two groups was evaluated through a controlled study, while wound exudates were collected only from the experimental group before and after treatment for 16S rDNA sequencing and metabolomics analysis to evaluate changes in wound microbiota and metabolites. Results: Following the treatment, the granulation tissue coverage, wound healing rate, and Maryland Foot Function Score in the experimental group were markedly superior to those of the control group. Post-treatment analysis revealed significant changes in the wound microbiota composition of the trial group, with a reduction in potential pathogenic bacteria, including Erysipelatoclostridium, Lachnoclostridium, Pontimonas, Hydrogenovibrio, and Aquabacterium, alongside an increase in beneficial bacteria, such as Cetobacterium and Allisonella. Furthermore, 4,034 differential metabolites were identified, with 1907 upregulated and 2,127 downregulated, involving key metabolic pathways such as phenylpropanoid biosynthesis, tyrosine metabolism, and amino acid biosynthesis. Correlation analysis indicated a strong negative association between Pontimonas, Hydrogenovibrio, Aquabacterium, and the majority of the differential metabolites. Conclusion: The Shengji ointment combined with bromelain has shown notable effectiveness in treating diabetic foot wounds with tendon exposure by modulating microbial composition (reducing pathogenic bacteria and increasing beneficial bacteria) and optimizing the metabolic environment (targeting key metabolic pathways), providing valuable insights for further exploration of its mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.